Jamal Alhiyafi

Dr. Jamal Alhiyafi

Kettering University
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
NANjoud Abdullah Almansour
Njoud Abdullah Almansour
HSHajra Fahim Syed
Hajra Fahim Syed
NKNuha Radwan Khayat
Nuha Radwan Khayat
RARawan Kanaan Altheeb
Rawan Kanaan Altheeb
RJRenad Emad Juri
Renad Emad Juri
SOSunday Olusanya Olatunji
Sunday Olusanya Olatunji

1 April 2021 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
SOSunday O. Olatunji
Sunday O. Olatunji
SASarah Alotaibi
Sarah Alotaibi
EAEbtisam Almutairi
Ebtisam Almutairi
ZAZainab Alrabae
Zainab Alrabae
YAYasmeen Almajid
Yasmeen Almajid
JAJamal Alhiyafi
Jamal Alhiyafi

28 December 2021 in Sensors
Verified
Journal Article
Open access
PDF file
MAMaha M. AlShammari
Maha M. AlShammari
AAAfnan Almuhanna
Afnan Almuhanna
JAJamal Alhiyafi
Jamal Alhiyafi
A tumor is an abnormal tissue classified as either benign or malignant. A breast tumor is one of the most common tumors in women. Radiologists use mammograms to identify a breast tumor and classify it, which is a time-consuming process and prone to error due to the complexity of the tumor. In this study, we applied machine learning-based techniques to assist the radiologist in reading mammogram images and classifying the tumor in a very reasonable time interval. We extracted several features from the region of interest in the mammogram, which the radiologist manually annotated. These features are incorporated into a classification engine to train and build the proposed structure classification models. We used a dataset that was not previously seen in the model to evaluate the accuracy of the proposed system following the standard model evaluation schemes. Accordingly, this study found that various factors could affect the performance, which we avoided after experimenting all the possible ways. This study finally recommends using the optimized Support Vector Machine or Naïve Bayes, which produced 100% accuracy after integrating the feature selection and hyper-parameter optimization schemes.

SOSunday Olusanya Olatunji
Sunday Olusanya Olatunji
NANawal Alsheikh
Nawal Alsheikh
LALujain Mohammed Alnajrani
Lujain Mohammed Alnajrani
AAAlhatoon Alanazy
Alhatoon Alanazy
MAMeshael Almusairii
Meshael Almusairii
JAJamal Alhiyafi
Jamal Alhiyafi
Multiple Sclerosis (MS) is characterized by chronic deterioration of the nervous system, mainly the brain and the spinal cord. An individual with MS develops the condition when the immune system begins attacking nerve fibers and the myelin sheathing that covers them, affecting the communication between the brain and the rest of the body and eventually causing permanent damage to the nerve. Patients with MS (pwMS) might experience different symptoms depending on which nerve was damaged and how much damage it has sustained. Currently, there is no cure for MS; however, there are clinical guidelines that help control the disease and its accompanying symptoms. Additionally, no specific laboratory biomarker can precisely identify the presence of MS, leaving specialists with a differential diagnosis that relies on ruling out other possible diseases with similar symptoms. Since the emergence of Machine Learning (ML) in the healthcare industry, it has become an effective tool for uncovering hidden patterns that aid in diagnosing several ailments. Several studies have been conducted to diagnose MS using ML and Deep Learning (DL) models trained using MRI images, achieving promising results. However, complex and expensive diagnostic tools are needed to collect and examine imaging data. Thus, the intention of this study is to implement a cost-effective, clinical data-driven model that is capable of diagnosing pwMS. The dataset was obtained from King Fahad Specialty Hospital (KFSH) in Dammam, Saudi Arabia. Several ML algorithms were compared, namely Support Vector Machine (SVM), Decision Tree (DT), Logistic Regression (LR), Random Forest (RF), Extreme Gradient Boosting (XGBoost), Adaptive Boosting (AdaBoost), and Extra Trees (ET). The results indicated that the ET model outpaced the rest with an accuracy of 94.74%, recall of 97.26%, and precision of 94.67%.

1 January 2019 in Journal of Loss Prevention in the Process Industries
Verified
Journal Article
Closed access
TOTaoreed O. Owolabi
Taoreed O. Owolabi
MSMuhammad A. Suleiman
Muhammad A. Suleiman
HAHayatullahi B. Adeyemo
Hayatullahi B. Adeyemo
KAKabiru O. Akande
Kabiru O. Akande
JAJamal Alhiyafi
Jamal Alhiyafi
SOSunday O. Olatunji
Sunday O. Olatunji

23 August 2022 in Computational Intelligence and Neuroscience
Verified
Journal Article
Open access
PDF file
SOSunday Olusanya Olatunji
Sunday Olusanya Olatunji
AAAisha Alansari
Aisha Alansari
HAHeba Alkhorasani
Heba Alkhorasani
MAMeelaf Alsubaii
Meelaf Alsubaii
RSRasha Sakloua
Rasha Sakloua
JAJamal Alhiyafi
Jamal Alhiyafi
Alzheimer’s Disease (AD) is a silent disease that causes the brain cells to die progressively, influencing consciousness, behavior, planning ability, and language to name a few. AD increases exponentially with aging, where it doubles every 5-6 years, causing profound implications, such as swallowing difficulties and losing the ability to speak before death. According to the Ministry of Health in Saudi Arabia, AD patients will triple by 2060 to reach 14 million patients worldwide. The rapid rise of patients is caused by the silent progress of the disease, leading to late diagnosis as the symptoms will not be distinguished from normal aging affect. Moreover, with the current medical capabilities, it is impossible to confirm AD with 100% certainty via specific medical examinations. The literature review revealed that most recent publications used images to diagnose AD, which is insufficient for local hospitals with limited imaging capabilities. Other studies that used clinical and demographical data failed to achieve adequate results. Consequently, this study aims to preemptively predict AD in Saudi Arabia by employing machine learning (ML) techniques. The dataset was acquired from King Fahad Specialist Hospital (KFSH) in Dammam, Saudi Arabia, containing standard clinical tests for 152 patients. Four ML algorithms, namely, support vector machine (SVM), k-nearest neighbors (k-NN), Adaptive Boosting (AdaBoost), and eXtreme Gradient Boosting (XGBoost), were employed to preemptively diagnose the disease. The empirical results demonstrated the robustness of SVM in the pre-emptive diagnosis of AD with accuracy, precision, recall, and area under the receiver operating characteristics (AUROC) of 95.56%, 94.70%, 97.78%, and 0.97, respectively, with 13 features after applying the sequential forward feature selection technique. This model can assist the medical staff in controlling the progression of the disease at low costs.